Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. [electronic resource]
Producer: 20040930Description: S42-66 p. digitalISSN:- 1055-0496
- Administration, Sublingual
- Adult
- Buprenorphine -- adverse effects
- Community Health Services
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Approval -- legislation & jurisprudence
- Drug Therapy, Combination
- Humans
- Male
- Middle Aged
- Multicenter Studies as Topic
- Naloxone -- adverse effects
- Narcotic Antagonists -- adverse effects
- Narcotics -- adverse effects
- National Institutes of Health (U.S.)
- Opioid-Related Disorders -- rehabilitation
- Randomized Controlled Trials as Topic -- legislation & jurisprudence
- Rehabilitation Centers
- Substance Withdrawal Syndrome -- drug therapy
- Time Factors
- United States
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.